Ensures Freedom to Breathe

COMPOSITION: Montelukast 4 mg + Levocetirizine 2.5 mg 


Montelukast (Leukotriene receptor antagonists (LTRAs))

  • Because asthma and atopic dermatitis have a similar pathogenesis, leukotriene inhibitors may have a role in the treatment of atopic dermatitis.

Levocetirizine (Second-generation histamine H(1) antagonist)

  • Levocetirizine was more effective (in controlling the symptoms of SAR) than fexofenadine at and later than 22 h after drug intake, an indication of the longer duration of action of levocetirizine.


  • The combination therapy of montelukast with antihistaminic (Levocetirizine) provides enhancing and complementary effects, thereby reducing the symptoms of allergic rhinitis (AR) effectively.